Definitive Contract HHSN268201400044C
Award Date 9/8/14
Potential Completion Date 8/7/18
Potential Value $1.6M
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Belmont, MA 02478, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
8
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
SBIR Program Phase I Action
Primary Consortia Member
Not listed Similar Awards
- This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Heart, Lung, and Blood Institute (NHLBI), a civilian agency of the U.S. government. The contract, valued at $224,944.00, was awarded to Sibtech, Inc. on September 8, 2014 and has a completion date of December 7, 2015. The contract aims to develop specific molecular imaging agents that can be used in combination with existing imaging modalities to detect high-risk atherosclerotic plaque. This research...
- This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Heart, Lung, and Blood Institute (NHLBI), a civilian agency, to Molecular Targeting Technologies, Inc. (MTTI), a small disadvantaged business. The $222,581 firm fixed-price contract supports the development of target-specific molecular imaging agents to be used in combination with existing imaging modalities to detect high-risk atherosclerotic plaque. This SBIR contract falls under Topic 85 and is set...
- This federal contract award of $224,973 was made by the National Heart Lung and Blood Institute (NHLBI), a civilian agency, to Nanohybrids Inc., a for-profit company. The contract is for the development of target-specific molecular imaging agents to detect high-risk atherosclerotic plaque, under the Small Business Innovation Research (SBIR) program. The contract is a Definitive Contract, Firm Fixed Price type, with a completion date of September 7, 2015. There is no set-aside designation...
- This is a $97,680 firm fixed price contract awarded by the National Heart Lung and Blood Institute, a civilian agency within the U.S. Department of Health and Human Services. The contract was set aside for small businesses and awarded to Mediomics LLC, a woman-owned small business. The contract is for the development of APTAMER-BASED PINCERS FOR CARDIOVASCULAR BIOMARKERS, which aligns with the National Heart Lung and Blood Institute's mission to support research on heart, lung, and blood...
- This is a $1,725,000.00 Small Business Innovation Research (SBIR) Phase I contract awarded by the National Heart, Lung, and Blood Institute (NHLBI), a component of the U.S. Department of Health and Human Services (HHS), to Ocean Nano TECH LLC, a woman-owned small disadvantaged business. The contract is for the development of targeted molecular imaging agents to detect high-risk atherosclerotic plaque, in combination with existing imaging modalities. Ocean Nano TECH LLC is a nanotechnology...
- <p>This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Heart Lung and Blood Institute (NHLBI), a civilian agency within the U.S. Department of Health and Human Services. The contract, valued at $279,113, was awarded to Gwathmey, Inc. on August 26, 2009 for biomedical (applied/exploratory) research. The contract has a firm fixed price pricing type and a completion date of September 30, 2010.</p>
- This is a $3,412,128 Firm Fixed Price contract awarded by the National Heart, Lung, and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to Transmural Systems LLC, a woman-owned small business. The contract is for Phase I of a Fast-Track Small Business Innovation Research (SBIR) award focused on "Devices for Transcatheter Surgery". The original solicitation was part of the NIH/CDC SBIR Contract Solicitation PHS 2018-1, which sought proposals from small...
- <p>This is a $215,489.60 definitive contract award from the National Heart, Lung, and Blood Institute (NHLBI), a civilian agency, to MRI Interventions Inc. for SBIR (Small Business Innovation Research) Topic 076, Phase II, for the development of an MRI Myocardial Biopsy Forceps. The contract is set aside for small businesses and has a period of performance ending on September 17, 2016. The contract is a cost-no-fee type, indicating the contractor is not receiving a fee for their efforts.</p>
- This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Heart Lung and Blood Institute (NHLBI), a civilian agency, to Aphios Corp, a minority-owned for-profit small business. The contract has a ceiling value of $149,440 and a completion date of December 14, 2011. It was awarded on June 15, 2011 under the SBIR program to support research related to Topic 43. SBIR contracts provide early-stage funding to small businesses for the development of innovative...
- This federal contract award, identified as HHSN268201200064C, was made by the National Heart Lung and Blood Institute (NHLBI), a civilian agency of the U.S. government, to HDL Apomics LLC, a small business. The $139,291.00 Firm Fixed Price contract is for "OTHER FUNCTIONS-ANTIBODY PROTEOMICS FOR MEASURING LIPOPROTEIN SUB-POPULATIONS" under the SBIR TOPIC 64 PHASE 1 - NOVEL TECHNOLOGIES FOR ASSESSING LIPOPROTEIN SUB-FRACTIONS program. The contract has a total small business set-aside...
This is a $1,591,490.86 Firm Fixed Price SBIR Phase I contract awarded by the National Heart, Lung and Blood Institute (NHLBI), a civilian agency, to Collagen Medical LLC, a for-profit limited liability company, to support the development of target-specific molecular imaging agents in combination with existing imaging modalities to detect high-risk atherosclerotic plaque. The contract is set aside for small businesses. Collagen Medical has previously received federal grants from the National Cancer Institute, the National Institute of Biomedical Imaging and Bioengineering, and the NHLBI to conduct research and development work in areas such as cancer, cardiovascular disease, and liver disease.
Generated 7/6/24, 9:18 AM
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
PHS 2014-1 Amendment 3 | PHS-2014-1 | Department of Health and Human Services National Institutes of Health | Award Notice 1/1 | 8/14/13, 6:51 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00006 | Close Out | $0 | 7/5/24 | |
| P00005 | Other Administrative Action | ($122k) | 4/17/20 | |
| 4 | Other Administrative Action | $0 | 8/31/17 | |
| 3 | Other Administrative Action | $0 | 3/22/16 | |
| 2 | Exercise an Option | $1.5m | 9/8/15 |